54 related articles for article (PubMed ID: 25509985)
21. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
[TBL] [Abstract][Full Text] [Related]
22. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
[TBL] [Abstract][Full Text] [Related]
23. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
Ui A; Yasui A
Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
[TBL] [Abstract][Full Text] [Related]
24. Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.
Leach BI; Kuntimaddi A; Schmidt CR; Cierpicki T; Johnson SA; Bushweller JH
Structure; 2013 Jan; 21(1):176-183. PubMed ID: 23260655
[TBL] [Abstract][Full Text] [Related]
25. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
[TBL] [Abstract][Full Text] [Related]
26. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
Monroe SC; Jo SY; Sanders DS; Basrur V; Elenitoba-Johnson KS; Slany RK; Hess JL
Exp Hematol; 2011 Jan; 39(1):77-86.e1-5. PubMed ID: 20854876
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.
Sobhian B; Laguette N; Yatim A; Nakamura M; Levy Y; Kiernan R; Benkirane M
Mol Cell; 2010 May; 38(3):439-51. PubMed ID: 20471949
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.
He N; Liu M; Hsu J; Xue Y; Chou S; Burlingame A; Krogan NJ; Alber T; Zhou Q
Mol Cell; 2010 May; 38(3):428-38. PubMed ID: 20471948
[TBL] [Abstract][Full Text] [Related]
29. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
Lin C; Smith ER; Takahashi H; Lai KC; Martin-Brown S; Florens L; Washburn MP; Conaway JW; Conaway RC; Shilatifard A
Mol Cell; 2010 Feb; 37(3):429-37. PubMed ID: 20159561
[TBL] [Abstract][Full Text] [Related]
30. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
[TBL] [Abstract][Full Text] [Related]
31. Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.
Bennett CA; Winters AC; Barretto NN; Hemenway CS
Leuk Res; 2009 Jul; 33(7):937-47. PubMed ID: 19232721
[TBL] [Abstract][Full Text] [Related]
32. The AF4-mimetic peptide, PFWT, induces necrotic cell death in MV4-11 leukemia cells.
Palermo CM; Bennett CA; Winters AC; Hemenway CS
Leuk Res; 2008 Apr; 32(4):633-42. PubMed ID: 17875318
[TBL] [Abstract][Full Text] [Related]
33. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
Bitoun E; Oliver PL; Davies KE
Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
[TBL] [Abstract][Full Text] [Related]
34. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Hilden JM; Dinndorf PA; Meerbaum SO; Sather H; Villaluna D; Heerema NA; McGlennen R; Smith FO; Woods WG; Salzer WL; Johnstone HS; Dreyer Z; Reaman GH;
Blood; 2006 Jul; 108(2):441-51. PubMed ID: 16556894
[TBL] [Abstract][Full Text] [Related]
35. hDOT1L links histone methylation to leukemogenesis.
Okada Y; Feng Q; Lin Y; Jiang Q; Li Y; Coffield VM; Su L; Xu G; Zhang Y
Cell; 2005 Apr; 121(2):167-78. PubMed ID: 15851025
[TBL] [Abstract][Full Text] [Related]
36. The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells.
Srinivasan RS; Nesbit JB; Marrero L; Erfurth F; LaRussa VF; Hemenway CS
Leukemia; 2004 Aug; 18(8):1364-72. PubMed ID: 15269783
[TBL] [Abstract][Full Text] [Related]
37. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Pui CH; Gaynon PS; Boyett JM; Chessells JM; Baruchel A; Kamps W; Silverman LB; Biondi A; Harms DO; Vilmer E; Schrappe M; Camitta B
Lancet; 2002 Jun; 359(9321):1909-15. PubMed ID: 12057554
[TBL] [Abstract][Full Text] [Related]
38. Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Blanco JG; Dervieux T; Edick MJ; Mehta PK; Rubnitz JE; Shurtleff S; Raimondi SC; Behm FG; Pui CH; Relling MV
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10338-43. PubMed ID: 11526240
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
